Home Teva Agrees to Buy NuPathe for $144 Million, Outbidding Endo
 

Keywords :   


Teva Agrees to Buy NuPathe for $144 Million, Outbidding Endo

2014-01-21 19:16:48| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. agreed to buy NuPathe Inc. for $144 million, outbidding Endo Health Solutions Inc. to gain NuPathe's migraine patch.

Tags: buy million agrees endo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
08.10Personal Care Solutions Debuts New Website
08.10Hurricane Milton Probabilistic Storm Surge Graphics
08.10PRINTING United Alliance announces leadership changes
08.10Axalta Schedules 3Q 2024 Earnings Conference Call
08.10Hurricane Milton Graphics
08.10Hurricane Milton Storm Surge Watch/Warning Map
08.10Hurricane Milton Wind Speed Probabilities Number 14
08.10Hurricane Milton Public Advisory Number 14
More »